In this regard, EGFR, PTEN, ESR1, FGFR2 and ERBB2 were more frequently detected in CSF ctDNA than in blood in a cohort of NSCLC and BC [86] as well as in patients with melanoma and negative CSF cytology [87]. This evidence concerns the gene ESR1 and breast cancer.